We are live on !
Find out more
McAdam LLC Portfolio holdings
AUM
$2.66B
Turnover
19.38%
1-Year Est. Return
14.82%
This Fund
S&P 500
This Quarter Est. Return
+1.6%
1 Year Est. Return
+14.82%
3 Year Est. Return
+65.37%
5 Year Est. Return
+53.95%
10 Year Est. Return
+151.29%
AUM
$246M
AUM Growth
+$27.9M
(+13%)
Cap. Flow
+$24.9M
Cap. Flow % of AUM
Cap. Flow %
10.14%
Top 10 Holdings %
Top 10 Hldgs %
64.81%
Holding
904
New
60
Increased
150
Reduced
131
Closed
202
Avg Time Held
0.3
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$2.75M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$2.47M |
| 3 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$2.28M |
| 4 |
Schwab International Equity ETF
SCHF
|
+$2M |
| 5 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$1.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$131K |
| 2 |
iShare MSCI Eurozone ETF
EZU
|
+$113K |
| 3 |
Vanguard Morningstar Growth ETF
VUG
|
+$104K |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$103K |
| 5 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$97.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.97% |
| 2 | Technology | 1.2% |
| 3 | Healthcare | 1.19% |
| 4 | Consumer Discretionary | 0.7% |
| 5 | Communication Services | 0.61% |
Similar funds
BS
FFH
McAdam LLC's Q2 2018 Portfolio in Review
As of Q2 2018, McAdam LLC held 904 positions worth $246M, up 13% from $218M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
McAdam LLC deployed $24.9M of net new capital in Q2 2018, opening 60 new positions and adding to 150 existing holdings. Its largest new stake was BrightSpire Capital: 7,203 shares worth $149K.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $131K trimmed.
- McAdam LLC's largest Q2 2018 buy was BrightSpire Capital: 7,203 shares worth $149K.
- McAdam LLC added most to Schwab Fundamental US Large Company Index ETF in Q2 2018, an estimated $2.75M increase.
- McAdam LLC's biggest Q2 2018 reduction was Vertex Pharmaceuticals, cutting an estimated $131K.
- McAdam LLC fully exited ProShares Short S&P500 in Q2 2018, selling an estimated $76K.
- McAdam LLC's ten largest holdings make up 65% of its $246M portfolio in Q2 2018.
- McAdam LLC opened 60 new positions and closed 202 in Q2 2018.
- McAdam LLC's portfolio value rose 13% quarter-over-quarter to $246M.
Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.